TITLE

Persistent microhaematuria with negative or low proteinuria

AUTHOR(S)
Gutiérrez, Eduardo; Moreno, Juan A.; Praga, Manuel
PUB. DATE
January 2014
SOURCE
Nefrologia;2014, Vol. 34 Issue 1, p110
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The level of proteinuria continues to be the clinical parameter that is best related to the development of long-term renal failure in glomerular pathologies. This quantity is particularly important when we analyse the progression of patients with IgA nephropathy. As such, the natural progression of patients with IgA who clinically present with normal kidney function, microhaematuria and low proteinuria had not been analysed comprehensively until the Spanish multicentre study herein analysed. After studying 141 Caucasian patients with biopsied IgA nephropathy and a "benign" clinical profile and after they were classified histologically in accordance with the new Oxford classification, it could be concluded that the renal prognosis of these patients was excellent. This is the first study in the literature that demonstrates the usefulness of this new classification in patients who clinically have normal renal function and proteinuria below 0.5g/day. The latest advances in the genetics of this disease, as well as in the collaboration of complement pathways in its pathophysiology mean that these results cannot be extrapolated to all the populations studied. In addition, the analysis and follow-up of microhaematuria has regained importance as an independent prognostic factor for developing renal failure, although there are no consistent studies in this regard yet. However, it is a subject that should be examined again by the nephrology community.
ACCESSION #
94088051

 

Related Articles

  • Steroids in the Treatment of IgA Nephropathy to the Improvement of Renal Survival: A Systematic Review and Meta-Analysis. Yu-Hao Zhou; Li-Gong Tang; Shi-Lei Guo; Zhi-Chao Jin; Mei-Jing Wu; Jia-Jie Zang; Jin-Fang Xu; Chun-Fang Wu; Ying-Yi Qin; Qing Cai; Qing-Bin Gao; Shan-Shan Zhang; Dand-Hui Yu; Jia He // PLoS Clinical Trials;Apr2011, Vol. 8 Issue 4, Special section p1 

    Background: Studies have shown that steroids can improve kidney survival and decrease the risk of proteinuria in patients with Immunoglobulin A nephropathy, but the overall benefit of steroids in the treatment of Immunoglobulin A nephropathy remains controversial. The aim of this study was to...

  • IgA nephropathy in a patient presenting with scleritis. Teixeira, Catarina; Quintas, Ana Miguel; Lopes, José António; Miranda, Margarida; de Almeida, Edgar // NDT Plus;Oct2010, Vol. 3 Issue 5, p453 

    Scleritis is a very uncommon manifestation in patients with IgA nephropathy. Here, we report the case of a patient presenting with diffuse anterior scleritis in which the laboratory disclosed microscopic haematuria and nephrotic range proteinuria. Renal function was normal. Serology for lupus,...

  • Activated complement C3: A potentially novel predictor of progressive IgA nephropathy. Zwirner, Jörg; Burg, Michael; Schulze, Matthias; Brunkhorst, Reinhard; Götze, Otto; Koch, Karl-Martin; Floege, Jürgen // Kidney International;Apr1997, Vol. 51 Issue 4, p1257 

    In the search for a serologic marker of disease activity, we measured concentrations of activated C3 (actC3, that is, neoantigens developing after C3 activation on breakdown products), C4-C3 complexes and soluble C5b-9 (sC5b-9) in one or two plasma samples from adult patients with IgA...

  • Immunoregulatory factors in the pathogenesis of IgA nephropathy. Emancipator, Steven N. // Kidney International;Dec1990, Vol. 38 Issue 6, p1216 

    The article presents information on two medical cases related to pathogenesis of IgA nephropathy (IgAN). The first phase of investigation of IgAN consists of a descriptive collation of clinical and/or pathologic features. Nearly all patients with IgAN (95%) have hematuria sometime during the...

  • Clinicopathologic findings relevant to disappearance or relapse of proteinuria following corticosteroid treatment in IgA nephropathy patients with proteinuria of 0.5 to 2.0?g/day. Suzuki, Takayuki; Yamamoto, Tatsuo; Ohura, Masaharu; Fujigaki, Yoshihide; Yonemura, Katsuhiko; Kimura, Masato; Hishida, Akira // Clinical & Experimental Nephrology;Sep2004, Vol. 8 Issue 3, p243 

    Background. We investigated the clinical and pathological findings relevant to the efficacy of corticosteroid treatment in IgA nephropathy patients with 0.5 to 2.0 g/day of proteinuria at the initiation of corticosteroid treatment. Methods. In 27 IgA nephropathy patients who received 2-year...

  • Evidence-based classification of glomerular pathology. Cook, Terry; Roberts, Ian S D; Feehally, John; Barratt, Jonathan // Kidney International;Nov2014, Vol. 86 Issue 5, p1059 

    A letter to the editor is presented in response to an article about the Oxford Classification of IgA Nephropathy as evidence-based classification of glomerular disease.

  • Proteinuria in IgA nephropathy. Neelakantappa, Kotresha; Gallo, Gloria R.; Baldwin, David S. // Kidney International;Mar1988, Vol. 33 Issue 3, p716 

    Clinicopathological data in 74 patients with IgA nephropathy were analyzed with special attention to level of proteinuria and its prognostic significance in this disease. Excretion rates exceeding 3 g per day (heavy), in the range of 1 to 2.9 g (moderate) and under 1 g per day (mild) each...

  • Significance of tonsillectomy combined with steroid pulse therapy for IgA nephropathy with mild proteinuria. Komatsu, Hiroyuki; Sato, Yuji; Miyamoto, Tetsu; Tamura, Masahito; Nakata, Takeshi; Tomo, Tadashi; Nishino, Tomoya; Miyazaki, Masanobu; Fujimoto, Shouichi // Clinical & Experimental Nephrology;Feb2016, Vol. 20 Issue 1, p94 

    Background: Medical intervention for patients with IgA nephropathy and mild proteinuria (<1.0 g/day) is controversial, and the effectiveness of tonsillectomy plus steroid pulse therapy (TSP) for such patients remains obscure. Methods: Among 323 patients in our multicenter cohort study, 79 who...

  • Steroids in the Treatment of IgA Nephropathy to the Improvement of Renal Survival: A Systematic Review and Meta-Analysis. Yu-Hao Zhou; Li-Gong Tang; Shi-Lei Guo; Zhi-Chao Jin; Mei-Jing Wu; Jia-Jie Zang; Jin-Fang Xu; Chun-Fang Wu; Ying-Yi Qin; Qing Cai; Qing-Bin Gao; Shan-Shan Zhang; Dand-Hui Yu; Jia He // PLoS ONE;2011, Vol. 6 Issue 4, p1 

    Background: Studies have shown that steroids can improve kidney survival and decrease the risk of proteinuria in patients with Immunoglobulin A nephropathy, but the overall benefit of steroids in the treatment of Immunoglobulin A nephropathy remains controversial. The aim of this study was to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics